Platelets in Skin Autoimmune Diseases

Area of Science:

• Immunology
• Dermatology
• Rheumatology

Background:

• Systemic lupus erythematosus (SLE), systemic sclerosis (SSc), and small vessel vasculitis are autoimmune diseases with significant skin manifestations.
• These conditions share pathogenic features like autoantibody production, fibrosis, and coagulation system activation.
• Platelets, traditionally known for hemostasis, increasingly show crucial immunoregulatory roles.

Purpose of the Study:

• To review the inflammatory functions of platelets.
• To elucidate the mechanistic contribution of platelet activation to the pathophysiology of SSc, ANCA-associated vasculitis, and other autoimmune skin diseases.

Main Methods:

• Review of current literature on platelet immunology and autoimmune diseases.
• Analysis of platelet activation pathways and their interaction with other immune cells and endothelium.
• Discussion of the role of platelet-derived factors and microparticles in disease pathogenesis.

Main Results:

• Platelets express immune receptors and release immunoactive molecules, contributing to inflammation.
• Platelet activation can be triggered by damage-associated molecular patterns (DAMPs), immune complexes, and complement.
• Activated platelets promote inflammatory environments through crosstalk with endothelium and leukocytes.

Conclusions:

• Platelet activation is a significant factor in the pathogenesis of autoimmune skin diseases.
• Targeting platelet functions presents a promising avenue for novel therapeutic strategies.
• Further research into platelet immunobiology is essential for developing effective treatments for SLE, SSc, and vasculitis.